The abstract is read at the publisher; the summary is JClub's.
Individuals with neurofibromatosis type 1 have markedly higher risk of atopic multimorbidity, including atopic keratoconjunctivitis (aHR = 17.35; 95% CI = 6.92–43.50).
- Why it matters: It is unclear whether neurofibromin-related neuroimmune dysregulation seen locally also produces a clinically meaningful systemic inflammatory phenotype.
- What they did: Using TriNetX, 23,218 people with neurofibromatosis type 1 were propensity score–matched 1:1 to controls, and Cox models estimated adjusted hazard ratios for new atopic diagnoses.
- The result: Neurofibromatosis type 1 is linked to elevated hazards for atopic dermatitis (aHR = 7.45), asthma (aHR = 4.68), allergic rhinitis (aHR = 7.15), urticaria (aHR = 3.54), and atopic keratoconjunctivitis (aHR = 17.35), with stronger effects in adults, females, and other racial groups.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.